MNKD
Mannkind Corporation
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$5.78
$-0.43
(-6.92%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $1.77B | EPS (ttm) | $0.10 | Current Price | $5.78 |
| Enterprise Value | $1.74B | Forward EPS | $0.15 | Previous Close | $6.21 |
| P/E Ratio | 57.80 | ROA | 9.95% | 52W High | $6.51 |
| Forward P/E | 39.41 | ROE | - | 52W Low | $3.38 |
| PEG Ratio | - | Gross Margin | 75.18% | 50 Day Avg | $5.68 |
| P/S Ratio | 5.66 | Operating Margin | 22.86% | 200 Day Avg | $4.88 |
| P/B Ratio | -39.86 | Profit Margin | 9.32% | Volume | 4.26M |
| EV/EBITDA | 20.54 | Current Ratio | 3.29 | Avg Volume | 3.77M |
| EV/Sales | 5.55 | Quick Ratio | 2.56 | Beta | 0.76 |
| Employees | 403.00 | Debt/Equity | - | Shares Outstanding | 307.07M |
| Sector | Healthcare | Total Debt | $225.43M | Float Shares | 301.61M |
| Industry | Biotechnology | Total Cash | $260.04M | Short Float | 9.02% |
| Optionable | Yes | Cash/Share | $0.85 | Short Ratio | 7.53 |
| Dividend Yield | - | Book Value/Share | $-0.14 | % Held by Insiders | 1.71% |
| Target Price | $9.61 | Revenue (TTM) | $313.79M | % Held by Institutions | 57.21% |